articleThe LancetMar 1, 2010Closed access

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

FJFrederick J. RaalRDRaúl D. SantosDBDirk BlomADA. David MaraisMCMin‐Ji Charng

University of the Witwatersrand · Universidade de São Paulo · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

903
total citations
FWCI
68.23
Percentile
100%
References
37
Citations per year

Authors

13

Topics & keywords

Topics
Keywords
  • Medicine
  • Placebo
  • Familial hypercholesterolemia
  • Internal medicine
  • Apolipoprotein B
  • Gastroenterology
  • Clinical endpoint
  • Cholesterol
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding